The Stem Cell Transplant Fellowship Training Program at TUMS Hematology-Oncology and Stem Cell Transplantation Research Center offers a one-year opportunity for board-certified physicians in the field of internal medicine, particularly hematologists-oncologists who wish to pursue further training in stem cell transplantation.
Duration: Minimum one year.
Positions offered per year: Twice per year.
Director: Ardeshir Ghavamzadeh, M.D.
Hematologist-Oncologist, Professor of Internal Medicine
Email: horcbmt@sina.tums.ac.ir
TUMS Hematology-Oncology and Stem Cell Transplantation Research Center, with a total area of 4,800 square meters, is based at Shariati Hospital. This Institute consists of a medical oncology ward, a hematology ward, BMT wards (adults and pediatrics), a post-bone marrow transplant ward, an emergency ward, as well as well-equipped laboratories. This research center, with more than 5,000 transplants including mesenchymal stem cell transplantation, autologous and allogeneic HSCT from related and unrelated donors or haploidentical and umbilical cord blood transplantation, is one of the largest stem cell transplant centers in the world. Since its establishment in 1991, the medical team in charge of this has acquired extensive experience in providing clinical services and treatment for a variety of malignant/non-malignant hematologic disorders including leukemia, inherited abnormalities of RBC, plasma cell disorders, lymphomas, severe aplastic anemia, MDS/MPs, solid tumors, disorders of the immune system, auto-immune diseases, inherited disorders of metabolism, and histiocytic disorders.
The aims of the transplant fellowship training program are focused on assessing the status of patients’ before transplantation, identifying and selecting stem cell sources, using donor registries, utilizing different methods of HLA typing and cryopreservation for storing stem cells, identifying indications for transplantation, administering high-dose chemotherapies, managing neutropenic fever and bacterial/viral/fungal diseases in patients, and diagnosing and managing acute/chronic GvHD and regimen-related toxicities.
Fellows will participate in both inpatient and outpatient care settings, and they are expected to become involved in clinical research projects. They must also actively participate in slide interpretation classes, tumor boards, the journal club, conferences held at national and international levels, weekly conferences, and one-day seminars.
How to apply
Applicants are requested to submit their application via the TUMS online application system.
Language of instruction for this training course is either English or Persian.
More Information
TUMS Hematology-Oncology and Stem Cell Transplantation Research Center
Shariati Hospital, Kargar Ave. Tehran 14114, Iran.
Phone: (+98 21) 8800 4140
Fax: (+98 21) 8802 9397
For furture information, please visit the HORCSCT website.